A Day in the Life of Chemo

Anyone who has ever been through chemo knows it is not a walk in the park. In fact, how you feel from minute to minute can change significantly. In fact, one such chemo patient described a recent day on a lymphoma forum.

Minute to minute daily chemo pattern:

  • feel shitty
  • feel okay
  • need a nap
  • feel great
  • feel exhausted
  • need nap
  • hate you
  • love you
  • need a nap
  • feel shitty
  • feel okay
  • need nap
  • feel terrible
  • feel great
  • feel grumpy - need a nap
  • feel like killing something
  • love everybody
  • need a nap

....AND THAT JUST GETS US UP TO ABOUT MID-AFTERNOON.

If you or someone you know is going through chemo, what are some survival strategies you can offer?

A few must buy product tips from readers include Ambien CR, constipation medicine before you need it, unscented moisturizer, hat to sleep in, plastic tableware, and dry mouth products (Oasis and Biotene, for example.)

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap